We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Biofrontera Inc | NASDAQ:BFRIW | NASDAQ | Equity Warrant |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0134 | 72.83% | 0.0318 | 0.0186 | 0.03 | 0.0318 | 0.0249 | 0.025 | 7,812 | 21:12:41 |
Erica Monaco, Chief Executive Officer and Hermann Lübbert, Executive Chairman of Biofrontera Inc. will be meeting with registered investors in virtual one-on-one meetings and small-group sessions.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on PDT and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit https://www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T. Patel+1 212 201 6614tpatel@lhai.com
# # #
1 Year Biofrontera Chart |
1 Month Biofrontera Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions